ALBI-sarcopenia score as a predictor of treatment outcomes in hepatocellular carcinoma
Advancing Personalized Medicine in Hepatocellular Carcinoma (HCC): The Role of ALBI-Sarcopenia The journey towards personalized medicine in hepatocellular carcinoma (HCC) is witnessing significant advancements with the integration of the ALBI score and sarcopenia. A new validated score combining these factors has shown promise in predicting mortality in HCC patients, heralding a new era of precision … Read more